Wynnefield Capital Inc Landec Corp \Ca\ Call Options Transaction History
Wynnefield Capital Inc
- $172 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LNDC
# of Institutions
80Shares Held
21.6MCall Options Held
114KPut Options Held
82.1K-
Legion Partners Asset Management, LLC Los Angeles, CA2.95MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT2.14MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
-
325 Capital LLC New York, NY1.34MShares$00.0% of portfolio
-
Cove Street Capital, LLC El Segundo, CA1.28MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...